0001209191-15-026058.txt : 20150313
0001209191-15-026058.hdr.sgml : 20150313
20150313162746
ACCESSION NUMBER: 0001209191-15-026058
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150311
FILED AS OF DATE: 20150313
DATE AS OF CHANGE: 20150313
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043404176
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COOK JOSEPH C JR
CENTRAL INDEX KEY: 0001024003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 15699688
MAIL ADDRESS:
STREET 1: MOUNTAIN GROUP CAPITAL, LLC
STREET 2: 1600 DIVISION STREET, SUITE 580
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-03-11
0
0001446847
IRONWOOD PHARMACEUTICALS INC
IRWD
0001024003
COOK JOSEPH C JR
C/O IRONWOOD PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
1
0
0
0
Class A Common Stock
2015-03-11
4
S
0
2600
15.53
D
43975
D
Class A Common Stock
2015-03-12
4
S
0
1200
15.54
D
42775
D
Class B Common Stock
2015-03-12
4
S
0
2083
15.54
D
304080
D
Class B Common Stock
24000
I
By Farview Management Company, L.P.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.19 to $15.72, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.46 to $15.66, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation.
The reporting person is a general partner of Farview Management Company, L.P., the beneficial owner of the securities.
/s/ Halley E. Gilbert, Attorney-in-Fact
2015-03-13